Treatment of hypertensive disease with heparin and isobarin
Zanozdra, N.S.; Drozdov, D.D.; Luganskiĭ, I.N.; Bol'shakova, R.M.; Volkova, I.A.
Vrachebnoe Delo 5: 24-26
1971
ISSN/ISBN: 0049-6804 PMID: 5159473 Document Number: 39368
Document emailed within 1 workday
Related Documents
Lagasse, J.P.; Bahallah, M.L.; Salem, N.; Debillon, G.; Labarrière, D.; Serve, M.P.; Advenier, V.; Causse, X.; Legoux, J.L. 1997: Acute thrombosis of the portal system. Treatment with alteplase and heparin or with heparin alone in 10 patients Gastroenterologie Clinique et Biologique 21(12): 919-923Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Sibirkin, N.V.; Kozlovich, I.V.; Iazovitskaia, L.M. 1974: Experience with the treatment of hypertensive disease with octadin Klinicheskaia Meditsina 52(8): 62-67
Gouault-Heilmann, M.; Contant, G.; Pochmalicki, G.; Jan, F. 1984: Disseminated intravascular coagulation induced by heparin. Treatment with a combination of low-molecular weight heparin and concentrated antithrombin IIi Presse Medicale 13(22): 1393-1394
Hull, R.D.; Raskob, G.E.; Rosenbloom, D.; Pineo, G.F.; Lerner, R.G.; Gafni, A.; Trowbridge, A.A.; Elliott, C.G.; Green, D.; Feinglass, J. 1997: Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective Archives of Internal Medicine 157(3): 289-294
Verardi, S.; Ippoliti, A.; Pistolese, G.R. 1988: Antithrombotic treatment during acute inflammatory complications of patients affected by postphlebitic syndrome: LMW-heparin versus standard heparin International Angiology: a Journal of the International Union of Angiology 7(3 Suppl): 33-40
Zozulia, I.S. 1976: Use of papaverine and euphyllin in the complex treatment of hypertensive disease Vrachebnoe Delo 2: 27-30
Ianovskiĭ, G.V.; Zhadan, I.V. 1970: Treatment of early cardiac insufficiency in hypertensive disease Klinicheskaia Meditsina 48(4): 104-108
Erina, E.V. 1972: Several compensatory-adaptive reactions in the treatment of hypertensive disease Kardiologiia 12(5): 29-38
Vinichuk, S.M. 1976: Treatment of cerebral infarction in patients with hypertensive disease Vrachebnoe Delo 10: 93-97
Sidel'nikova, T.I.; Smelova, M.A.; Erina, E.V. 1975: Ambulatory treatment of hypertensive disease running its course with crises Terapevticheskii Arkhiv 47(12): 11-15
Schamaun, M.; Bernhardt, D.; Hörder, M.H. 1973: Significance of intravascular coagulation disease in postraumatic respiratory insufficiency. 1st experience with heparin treatment Schweizerische Medizinische Wochenschrift 103(26): 941-946
Gerasimenko, I.A. 1971: Significance of sanatorial treatment in the rehabilitation of patients with hypertensive disease Vrachebnoe Delo 2: 22-24
Shabanov, V.A.; Kitaeva, N.D.; Levin, G.Ia.; Karsakov, V.V.; Kostrov, V.A. 1991: Optimization of the treatment of patients with hypertensive disease from the rheological viewpoint Kardiologiia 31(2): 67-70
Osterkorn, D.; Schramm, W.; Szucs, T. 1996: Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home Medizinische Klinik 91(9): 607-609
Beheka, A.D.; Hroĭsman, S.D. 1975: The effect of different doses of the sympatholytic isobarin on the evacuatory function of the stomach in dogs Fiziolohichnyi Zhurnal 21(5): 649-653
Chen, J-lin.; Chen, J.; Qiao, S-bin.; Guo, Y-lin.; Wu, Y-jian.; Dai, J.; Yuan, J-qing.; Qin, X-wen.; Yang, Y-jin.; Gao, R-lin. 2006: A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease Chinese Medical Journal 119(5): 355-359
White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Akhmineeva, A.K. 2014: Biochemical markers of endothelial dysfunction in chronic obstructive pulmonary disease concurrent with hypertensive disease or coronary heart disease Terapevticheskii Arkhiv 86(3): 20-23
Bobrov, V.A. 1976: Acetylcholine-cholinesterase system in rheumatic heart disease associated with hypertensive disease Vrachebnoe Delo 6: 51-55